Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies [Phase 1]
Phase 1 clinical trial evaluating Sonrotoclax (BGB-11417), a Bcl-2 inhibitor, in participants with mature B-cell malignancies. The study is …
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma [Phase 1]
This report covers a Phase 1 clinical trial evaluating a personalized neoantigen cancer vaccine in combination with pembrolizumab after ritu…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial evaluating Rituximab plus Bendamustine and ibrutinib (PCI-32765) in relapsed DLBCL, mantle cell lymphoma, and various…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 2]
This document reports a Phase 2 clinical trial evaluating loncastuximab tesirine in combination with rituximab for relapsed or refractory fo…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies [Phase 1]
Phase 1 study evaluating NX-2127 in adults with relapsed or refractory B-cell malignancies; currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating ALX148 in combination with Rituximab and Lenalidomide for various B-cell non-Hodgkin lymphomas, with the trial …
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) [Phase 1]
A Phase 1 study of LY4152199 in previously treated B-cell cancers is listed, with the trial currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating mosunetuzumab plus lenalidomide in follicular lymphoma, and comparison of subcutaneous…
-
CLINICAL_TRIALS withdrawal · 2026-03-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma [Phase 3]
A Phase 3 trial evaluating lisocabtagene maraleucel (Liso-cel) versus standard of care in adults with relapsed or refractory follicular lymp…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma [Phase 1]
AstraZeneca reports a Phase 1 clinical trial of AZD0486 in B-cell non-Hodgkin lymphomas, including diffuse large B-cell lymphoma, high-grade…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma [Phase 3]
A Phase 3 trial evaluating the combination of ibrutinib and rituximab in treatment-naïve follicular lymphoma has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML [Phase 1]
Phase 1 trial update for voruciclib alone or with venetoclax in various B-cell malignancies and acute myeloid leukemia; the study has been t…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies [NA]
This clinical trial update describes an evaluation of MTM-H-001 injection in adults with relapsed or refractory B-cell lymphomas, with the s…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CD79b-19 CAR T cells for relapsed or refractory non-Hodgkin lymphoma, including several subtypes, is cur…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma [Phase 2]
Phase 2 clinical trial evaluating glofitamab and obinutuzumab in indolent non-Hodgkin lymphomas, including follicular lymphoma and marginal …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma [Phase 2]
This entry describes a Phase 2 clinical trial of low-dose mosunetuzumab for indolent B-cell lymphomas, currently recruiting at the Universit…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating valemetostat in combination with rituximab and lenalidomide for relapsed or refractory follicular lymp…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Odronextamab in Low Tumor Volume Advanced FL [Phase 2]
Phase 2 study evaluating odronextamab for low-tumor-volume advanced follicular lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy [Phase 2]
A Phase 2 clinical trial evaluating epcoritamab for patients with follicular lymphoma who did not achieve a complete response to upfront che…
-
EMA approval · 2026-03-12EMA Authorised: Yescarta (axicabtagene ciloleucel) — Kite Pharma EU B.V.
EMA authorised Yescarta (axicabtagene ciloleucel) from Kite Pharma EU B.V. for treatment of certain B-cell lymphomas including follicular ly…
-
EMA approval · 2026-03-12EMA Authorised: Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) (lenalidomide hydrochloride monohydrate) — Krka, d.d., Novo mesto
EMA authorised Lenalidomide Krka (lenalidomide hydrochloride monohydrate) for several hematologic malignancies, including multiple myeloma, …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies [Phase 1]
Phase 1 clinical trial update of BGB-21447, a Bcl-2 inhibitor developed by BeOne Medicines, evaluating safety and preliminary activity in mu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) [Phase 2]
This clinical trial update reports on a Phase 2 study of Zilovertamab Vedotin (MK-2140) as monotherapy and in combination for aggressive and…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma [Phase 2]
A Phase II clinical trial evaluates Axicabtagene Ciloleucel (axi-cel), a CD19 CAR-T therapy, in combination with radiotherapy for relapsed/r…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…